Moshe Manor - Net Worth and Insider Trading
Moshe Manor Net Worth
The estimated net worth of Moshe Manor is at least $5,750 dollars as of 2024-04-27. Moshe Manor is the President & CEO of Protalix BioTherapeutics Inc and owns about 5,000 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $5,750. Details can be seen in Moshe Manor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Moshe Manor has not made any transactions after 2017-05-16 and currently still holds the listed stock(s).
Transaction Summary of Moshe Manor
Moshe Manor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Moshe Manor owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Moshe Manor’s form 4 insider trades.
Insider Ownership Summary of Moshe Manor
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2017-05-16 | President & CEO |
Moshe Manor Latest Holdings Summary
Moshe Manor currently owns a total of 1 stock. Moshe Manor owns 5,000 shares of Protalix BioTherapeutics Inc (PLX) as of May 16, 2017, with a value of $5,750.
Latest Holdings of Moshe Manor
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2017-05-16 | 5,000 | 1.15 | 5,750 |
Holding Weightings of Moshe Manor
Moshe Manor Form 4 Trading Tracker
According to the SEC Form 4 filings, Moshe Manor has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 5,000 shares on May 16, 2017, which cost Moshe Manor around $40,500.
Insider Trading History of Moshe Manor
- 1
Moshe Manor Trading Performance
GuruFocus tracks the stock performance after each of Moshe Manor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Moshe Manor is -32.53%. GuruFocus also compares Moshe Manor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Moshe Manor within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Moshe Manor's insider trading performs compared to the benchmark.
Performance of Moshe Manor
Average Return
-48.8%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.69 | -32.53 | -20.48 | -48.8 | -29.37 | -29.16 |
| Relative Return to S&P 500(%) | 0.34 | -35.34 | -28.18 | -62.2 | -38.83 | -35.22 |
Moshe Manor Ownership Network
Ownership Network List of Moshe Manor
Ownership Network Relation of Moshe Manor
Moshe Manor Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Moshe Manor is the President & CEO of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Moshe Manor made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Moshe Manor Mailing Address
Above is the net worth, insider trading, and ownership report for Moshe Manor. You might contact Moshe Manor via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit Street, Science Park, #455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
